Corteva, Inc. $CTVA Holdings Decreased by PGGM Investments

PGGM Investments trimmed its position in Corteva, Inc. (NYSE:CTVA) by 47.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 640,956 shares of the company’s stock after selling 582,488 shares during the quarter. PGGM Investments owned approximately 0.09% of Corteva worth $42,963,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the company. Allstate Corp increased its holdings in shares of Corteva by 104.4% in the 4th quarter. Allstate Corp now owns 51,384 shares of the company’s stock valued at $3,444,000 after acquiring an additional 26,250 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC grew its stake in Corteva by 9.1% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock worth $112,000 after buying an additional 140 shares during the last quarter. Fisher Asset Management LLC grew its stake in Corteva by 16.6% during the 4th quarter. Fisher Asset Management LLC now owns 8,534 shares of the company’s stock worth $572,000 after buying an additional 1,214 shares during the last quarter. Choate Investment Advisors grew its stake in Corteva by 595.1% during the 4th quarter. Choate Investment Advisors now owns 30,465 shares of the company’s stock worth $2,042,000 after buying an additional 26,082 shares during the last quarter. Finally, Clearstead Advisors LLC grew its stake in Corteva by 9.3% during the 4th quarter. Clearstead Advisors LLC now owns 14,596 shares of the company’s stock worth $978,000 after buying an additional 1,247 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Up 0.0%

NYSE:CTVA opened at $79.57 on Tuesday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The stock has a market cap of $53.22 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 2.43 and a beta of 0.59. The business has a fifty day moving average of $81.32 and a 200-day moving average of $74.16. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the prior year, the business posted $1.13 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Rothschild & Co Redburn upped their price objective on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Argus upped their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. CICC Research upped their price objective on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Finally, Wells Fargo & Company upped their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Thirteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $88.14.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.